
CD47 - Wikipedia
CD47 (Cluster of Differentiation 47) also known as integrin associated protein (IAP) is a transmembrane protein that in humans is encoded by the CD47 gene. CD47 belongs to the …
CD47 – Knowledge and References – Taylor & Francis
CD47 renders malignant cells resistant to classic immune surveillance machinery and is now recognized as a fundamental driver of tumor growth. Under normal physiological conditions, …
巨噬细胞的免疫检查点:CD47-SIRPα - 知乎 - 知乎专栏
cd47是sirpα最主要的配体,其它的配体包括:表面活性蛋白a和d(sp-a和sp-d)。目前sirpα被研究的最透彻的功能是其抑制巨噬细胞的吞噬功能; cd47分子和sirpα分子结构以及信号通路示 …
CD47: Beyond an immune checkpoint in cancer treatment
2022年9月1日 · The transmembrane protein, CD47, is recognized as an important innate immune checkpoint, and CD47-targeted drugs have been in development with the aim of inhibiting the …
Deciphering the role of CD47 in cancer immunotherapy
2024年9月1日 · CD47 is highly expressed in cancers to prevent phagocytosis by phagocytes. Targeting CD47 has been verified as a promising therapeutic strategy in cancer …
CD47 - an overview | ScienceDirect Topics
CD47 is a transmembrane protein widely expressed in normal and tumoural cells; its receptor SIRPα is another ITIM-containing signalling protein, expressed on myeloid cells, especially …
The role of gene expression of CD47 in colorectal cancer (CRC).
2023年1月24日 · CD47 plays an important role in suppressing phagocytosis through binding to transmembrane protein SIRP-alpha on macrophages. Targeting CD47 is a novel strategy for …
CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions …
By binding to another cell surface glycoprotein, signal regulatory protein alpha (SIRP α), CD47 can regulate the function of cells in the monocyte/macrophage lineage. In this spotlight paper, …
CD47: role in the immune system and application to cancer therapy
Here, we review the role of CD47 in the maintenance of immune system homeostasis. We also depict three emerging CD47-targeting strategies for cancer therapy, including the use of …
Targeting CD47 as a therapeutic strategy: A common bridge in the ...
The use of anti-CD47 mAb to blockade CD47-SIRPα is a potential therapeutic strategy in the deadly duo of COVID-19 and cancer. Early detection of other signaling pathways such as anti …